[Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
作者信息
Bertulla A, Bertamino V, Solari E
出版信息
Ateneo Parmense 1. 1971 Mar-Apr;42(2):103-14.
PMID:5154400
Abstract
摘要
相似文献
1
[Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].硫酸新霉素与对氯苯氧丁酸乙酯联合治疗血脂异常
Ateneo Parmense 1. 1971 Mar-Apr;42(2):103-14.
2
[Importance of the clofibrat in the treatment of lipid metabolism disorders].[氯贝丁酯在脂质代谢紊乱治疗中的重要性]
Med Klin. 1968 Jan 26;63(4):139-42.
3
[Hyperlipidemias: occurrence, significance, therapy].[高脂血症：发生率、意义、治疗]
Med Welt. 1967 Aug 12;32:1848-60.
4
[Action mechanism and clinical success of Regelan (Clofibrate)].[氯贝丁酯的作用机制与临床疗效]
Wien Klin Wochenschr. 1967 Sep 29;79(39):716-20.
5
[Clinical-experimental studies on lipid metabolism using Regelan].使用Regelan进行的脂质代谢临床实验研究
Wien Klin Wochenschr. 1967 Sep 29;79(39):720-2.
6
7
[The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Z Gesamte Inn Med. 1966 Mar 15;21(6):169-72.
8
9
Clofibrate and androsterone effect on serum lipids.
Arch Intern Med. 1967 Jan;119(1):80-5.
10
[Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].[用对氯苯氧异丁酸乙酯对成年原发性高甘油三酯血症既往治疗抵抗病例进行长期治疗]
Dtsch Med Wochenschr. 1967 Dec 15;92(50):2302-8. doi: 10.1055/s-0028-1106136.
Zotero 插件